Skip to content

Collaborative Care Coordination Program for Alzheimer's Disease and Related Dementias

Collaborative Care Coordination Program for Alzheimer's Disease and Related Dementias (Co-CARE-AD)

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05281744
Acronym
Co-CARE-AD
Enrollment
2160
Registered
2022-03-16
Start date
2022-05-27
Completion date
2026-01-15
Last updated
2026-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer's Disease and Related Dementias (ADRD)

Keywords

dementia, informal caregiver, care consultation, care coordination

Brief summary

This is a randomized, pragmatic clinical trial to evaluate the effectiveness of a collaborative care-coordination program embedded in a health plan for people living with Alzheimer's disease and related dementias (ADRD) and their care partners versus usual care. The study population will include community-dwelling Medicare Advantage members living with ADRD and their care partners. Outcomes will be healthcare utilization outcomes of individuals with ADRD and include emergency department visits, outpatient visits, avoidable emergency department visits, and admission to long-term care facilities.

Interventions

BEHAVIORALDementia Care Consultation program

The Dementia Care Consultation program uses a telephone-based intervention to provide an in-depth, personalized service for individuals living with ADRD and their care partners. It consists of comprehensive needs assessments, creation and implementation of personalized care plans, monitoring and revising care plans, disease education and support coaching, referrals to community-based organizations for service and support, and access to assistance.

Sponsors

Harvard Pilgrim Health Care
Lead SponsorOTHER
Tufts Health Plan
CollaboratorUNKNOWN
National Institute on Aging (NIA)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Community-dwelling Tufts Health Plan Medicare Advantage members with ADRD and their caregivers will be selected to participate in the trial based on the following inclusion/

Exclusion criteria

Inclusion Criteria (for members with ADRD) * Member of Tufts Health Plan Medicare Advantage plan * Medical and pharmacy insurance coverage in at least the prior 12 months * Have ≥1 ICD-10-CM diagnosis code for ADRD or dispensing for pharmacological treatment for ADRD in the prior 12 months

Design outcomes

Primary

MeasureTime frameDescription
All-cause emergency department visitsby 12 monthsNumber of all-cause emergency department visits per member living with ADRD over the 12-month follow-up period.

Secondary

MeasureTime frameDescription
Outpatient visitsby 12 monthsNumber of outpatient visits per member living with ADRD over the 12-month follow-up period.
Avoidable emergency department visitsby 12 monthsNumber avoidable emergency department visits (defined using the validated New York University ED visit algorithm) per member living with ADRD over the 12-month follow-up period.
Admission to long-term care facilitiesby 12 monthsNumber of members living with ADRD with the first admission to long-term care facilities over the 12-month follow-up period.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORXiaojuan Li, PhD MSPH

Harvard Pilgrim Health Care Institute

PRINCIPAL_INVESTIGATORRichard Platt, MD MS

Harvard Pilgrim Health Care Institute

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026